Follow
Jai N. Patel, PharmD, BCOP, CPP
Jai N. Patel, PharmD, BCOP, CPP
Chair, Cancer Pharmacology & Pharmacogenomics, Levine Cancer Institute, Atrium Health
Verified email at atriumhealth.org
Title
Cited by
Cited by
Year
Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer
AA Khorana, GA Soff, AK Kakkar, S Vadhan-Raj, H Riess, T Wun, ...
New England Journal of Medicine 380 (8), 720-728, 2019
5322019
Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology
J Neuberger, J Patel, H Caldwell, S Davies, V Hebditch, C Hollywood, ...
Gut 69 (8), 1382-1403, 2020
1282020
Clinical implementation of germ line cancer pharmacogenetic variants during the next‐generation sequencing era
NK Gillis, JN Patel, F Innocenti
Clinical Pharmacology & Therapeutics 95 (3), 269-280, 2014
692014
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced NeuropathyVAC14 SNP Predicts …
DL Hertz, K Owzar, S Lessans, C Wing, C Jiang, WK Kelly, J Patel, ...
Clinical Cancer Research 22 (19), 4890-4900, 2016
462016
Acupuncture for cancer pain and symptom management in a palliative medicine clinic
KR Miller, JN Patel, JT Symanowski, CA Edelen, D Walsh
American Journal of Hospice and Palliative Medicine® 36 (4), 326-332, 2019
452019
A community-based multicenter trial of pharmacokinetically guided 5-fluorouracil dosing for personalized colorectal cancer therapy
JN Patel, BH O'Neil, AM Deal, JG Ibrahim, GB Sherrill, OA Olajide, ...
The oncologist 19 (9), 959-965, 2014
432014
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
JN Patel
Pharmacogenomics and personalized medicine, 65-77, 2016
422016
Colorectal cancer biomarkers in the era of personalized medicine
JN Patel, MK Fong, M Jagosky
Journal of personalized medicine 9 (1), 3, 2019
362019
Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration‐resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB …
JN Patel, C Jiang, DL Hertz, FA Mulkey, K Owzar, S Halabi, MJ Ratain, ...
Cancer 121 (7), 1025-1031, 2015
352015
The impact of skeletal muscle on the pharmacokinetics and toxicity of 5-fluorouracil in colorectal cancer
GR Williams, AM Deal, SS Shachar, CM Walko, JN Patel, B O’Neil, ...
Cancer chemotherapy and pharmacology 81, 413-417, 2018
332018
Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer
JN Patel, I Braicu, KM Timms, C Solimeno, P Tshiaba, J Reid, ...
British journal of cancer 119 (9), 1060-1066, 2018
322018
Lung cancer biomarkers, targeted therapies and clinical assays
JN Patel, JL Ersek, ES Kim
Translational Lung Cancer Research 4 (5), 503, 2015
322015
HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line …
KR Miller, JN Patel, Q Zhang, EJ Norris, J Symanowski, C Michener, ...
Gynecologic Oncology 149 (1), 155-162, 2018
312018
Personalizing aromatase inhibitor therapy in patients with breast cancer
IS Hamadeh, JN Patel, S Rusin, AR Tan
Cancer treatment reviews 70, 47-55, 2018
302018
Cancer pharmacogenomics: implications on ethnic diversity and drug response
JN Patel
Pharmacogenetics and Genomics 25 (5), 223-230, 2015
302015
Implications of genome‐wide association studies in cancer therapeutics
JN Patel, HL McLeod, F Innocenti
British journal of clinical pharmacology 76 (3), 370-380, 2013
272013
Rivaroxaban thromboprophylaxis in high-risk ambulatory cancer patients receiving systemic therapy: results of a randomized clinical trial (CASSINI)
AA Khorana, GA Soff, AK Kakkar, S Vadhan-Raj, H Riess, T Wun, ...
Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018
262018
Application of genotype-guided cancer therapy in solid tumors
JN Patel
Pharmacogenomics 15 (1), 79-93, 2014
252014
Evaluation of CYP 2C19 Genotype‐Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell Transplant
JN Patel, IS Hamadeh, M Robinson, Z Shahid, J Symanowski, ...
Clinical Pharmacology & Therapeutics 107 (3), 571-579, 2020
242020
Personalizing chemotherapy dosing using pharmacological methods
JN Patel, A Papachristos
Cancer chemotherapy and pharmacology 76, 879-896, 2015
242015
The system can't perform the operation now. Try again later.
Articles 1–20